They've already provided an update on the indicative trading result, which was not bad, and it did have a great exit with US sales of $2.43M USD in December.
Looking at the sales figures for the 1H 2022, it looks like they had a decent start in July/August, before sales fell into a hole in September, before steadily building up to a great finish in December. If they can keep up the progress hey made in the last 3 months of the year, it will set this up for a big re-rate in the near future
In the meantime, I'm hoping to get a bit more info on the level of access they have with hospitals, R&D plans and how they are managing their cash.
Ann: 1H22 Results Webcast details, page-10
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $1.580B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.34 | $2.24 | $2.151M | 944.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9090 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 15253 | 5 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |